Malcolm Hoenlein - DarioHealth Corp Independent Director
| DRIO Stock | USD 1.32 0.16 13.79% |
Director
Mr. Malcolm Hoenlein, Ph.D., is an Independent Director of the Company. Since 1986, Mr. Hoenlein has served as Chief Executive Officer and Executive Vice Chairman of the Conference of Presidents of Major American Jewish Organizations, the coordinating body on international and national concerns for 52 national American Jewish organizations. Previously, he served as the founding Executive Director of the Jewish Community Relations Council of Greater New York. Prior to that, he was the founding Executive Director of the Greater New York Conference on Soviet Jewry. A National Defense Fellow at the Near East Center of the University of Pennsylvania, Mr. Hoenlein taught International Relations in the Political Science Department and served as a Middle East specialist at the Foreign Policy Research Institute. In addition, he served on the editorial staff of ORBIS, the Journal of International Affairs. He serves as a director of several companies, Coronado Biosciences Inc., Nanox Technologies, Data to Life, Nuvo Corporationrationand WellSense Technologies since 2011.
| Age | 73 |
| Tenure | 13 years |
| Address | 322 West 57th St., New York, NY, United States, 10011 |
| Phone | 972 477 0637 7 |
| Web | https://www.dariohealth.com |
DarioHealth Corp Management Efficiency
The company has return on total asset (ROA) of (0.3251) % which means that it has lost $0.3251 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8604) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to drop to -1.17. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, DarioHealth Corp's Debt To Assets are very stable compared to the past year. As of the 23rd of April 2024, Asset Turnover is likely to grow to 0.36, though Non Currrent Assets Other are likely to grow to (4.8 M).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Martiny Harris | HealthStream | 59 | |
| Linda Rebrovick | HealthStream | 62 | |
| William Stead | HealthStream | 69 | |
| Deborah Tate | HealthStream | 61 | |
| Manu Rana | HealthEquity | 45 | |
| Savita Acharya | National Research Corp | 41 | |
| Frank Gordon | HealthStream | 55 | |
| JoAnn Martin | National Research Corp | 63 | |
| Adrian Dillon | HealthEquity | 63 | |
| Kjersti Kanne | National Research Corp | N/A | |
| Jeffrey McLaren | HealthStream | 51 | |
| Dale Polley | HealthStream | 67 | |
| Frank Corvino | HealthEquity | 68 | |
| Brita Eilertsen | National Research Corp | 53 | |
| Frank Medici | HealthEquity | 53 | |
| Michael Shmerling | HealthStream | 62 | |
| P Shastri | National Research Corp | 65 | |
| Donald Berwick | National Research Corp | 71 | |
| Michael Leavitt | HealthEquity | 66 | |
| Evelyn Dilsaver | HealthEquity | 62 | |
| Martin Harris | HealthStream | 61 | |
Management Performance
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 |
DarioHealth Corp Leadership Team
Elected by the shareholders, the DarioHealth Corp's board of directors comprises two types of representatives: DarioHealth Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DarioHealth. The board's role is to monitor DarioHealth Corp's management team and ensure that shareholders' interests are well served. DarioHealth Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DarioHealth Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zvi CPA, Treasurer CFO | ||
| Glen Moller, Director | ||
| Josh Fischer, Senior Compliance | ||
| Dov Oppenheim, CoFounder Chief | ||
| Rami Yehudiha, Director | ||
| Hila Karah, Director | ||
| Richard Anderson, President | ||
| Claudia Levi, Content Manager | ||
| Jean Muyl, Head America | ||
| Zvi David, Treasurer CFO | ||
| Yalon Farhi, Director | ||
| Erez Raphael, Chairman, CEO and Pres | ||
| Ori Zanco, Director | ||
| Mary Mooney, Vice Marketing | ||
| Limor Drezner, Chief Officer | ||
| Dennis McGrath, Director | ||
| Olivier Jarry, President and Chief Commercial Officer | ||
| Malcolm Hoenlein, Independent Director | ||
| Richard Stone, Independent Director | ||
| Tomer BenKiki, Chief Officer | ||
| Brian Harrigan, Senior Sales | ||
| Yossi Bahagon, Director | ||
| Yoav Shaked, Chairman of the Board | ||
| Dror Bacher, Chief Officer | ||
| Zvi BenDavid, CFO, Treasurer, Secretary | ||
| Allen Kamer, Director | ||
| Omar MD, Chief Officer |
DarioHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DarioHealth Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 | ||||
| Profit Margin | (2.92) % | ||||
| Operating Margin | (3.90) % | ||||
| Current Valuation | 26.9 M | ||||
| Shares Outstanding | 29.44 M | ||||
| Shares Owned By Insiders | 14.81 % | ||||
| Shares Owned By Institutions | 29.43 % | ||||
| Number Of Shares Shorted | 1.36 M | ||||
| Price To Earning | (2.30) X |
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with DarioHealth Stock
| 0.91 | DH | Definitive Healthcare Financial Report 2nd of May 2024 | PairCorr |
| 0.82 | GH | Guardant Health Upward Rally | PairCorr |
Moving against DarioHealth Stock
| 0.75 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.75 | STIM | Neuronetics Financial Report 14th of May 2024 | PairCorr |
| 0.48 | RCM | R1 RCM Inc Sell-off Trend | PairCorr |
| 0.41 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for DarioHealth Stock analysis
When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share 0.717 | Quarterly Revenue Growth (0.47) | Return On Assets (0.33) | Return On Equity (0.86) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.